Mutual of America Capital Management LLC Sells 5,228 Shares of Teleflex Incorporated $TFX

Mutual of America Capital Management LLC decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 19.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,692 shares of the medical technology company’s stock after selling 5,228 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Teleflex were worth $2,654,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of TFX. Cooke & Bieler LP grew its stake in Teleflex by 14.0% in the 2nd quarter. Cooke & Bieler LP now owns 1,205,964 shares of the medical technology company’s stock worth $142,738,000 after buying an additional 148,436 shares in the last quarter. Qube Research & Technologies Ltd grew its position in Teleflex by 100.1% in the second quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock worth $71,821,000 after acquiring an additional 303,521 shares in the last quarter. Norges Bank bought a new position in Teleflex in the second quarter valued at $65,826,000. AQR Capital Management LLC raised its position in Teleflex by 39.9% during the second quarter. AQR Capital Management LLC now owns 409,320 shares of the medical technology company’s stock valued at $48,447,000 after purchasing an additional 116,797 shares in the last quarter. Finally, Boston Partners lifted its stake in Teleflex by 112.5% during the second quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock worth $45,085,000 after purchasing an additional 201,652 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Wells Fargo & Company reduced their price objective on Teleflex from $139.00 to $116.00 and set an “equal weight” rating on the stock in a research report on Thursday. Wall Street Zen cut shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Saturday, November 15th. Needham & Company LLC upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price objective for the company in a report on Tuesday. Truist Financial upped their price objective on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a research report on Wednesday, December 17th. Two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $139.00.

Teleflex Trading Down 1.0%

Shares of TFX opened at $104.40 on Friday. The stock has a market capitalization of $4.61 billion, a P/E ratio of -14.20, a PEG ratio of 1.38 and a beta of 0.93. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $184.34. The company has a quick ratio of 1.53, a current ratio of 2.57 and a debt-to-equity ratio of 0.67. The firm has a fifty day simple moving average of $116.10 and a two-hundred day simple moving average of $119.60.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a $0.34 dividend. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is -18.50%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.